Patient, X .
HRN: 22-19-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/14/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/14/2022
11/20/2022
IV
500mg
Q8
Intraabdominal Infection
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes